Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes

Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes

Show other versions (1)

Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor linaglipti...

Full description

Bibliographic Details
Main Author:	Thomas Haak
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-01-01
Series:	Clinical Medicine Insights: Endocrinology and Diabetes
Online Access:	https://doi.org/10.4137/CMED.S10360

Similar Items

Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
by: Thomas Haak
Published: (2015-01-01)

Comparison of Therapeutic Effects of Linagliptin and Metformin in Patients with Type 2 Diabetes: A systematic Review and Meta-Analysis
by: Hamidreza Dehghan, et al.
Published: (2018-04-01)

4.6 Effects of Combined Therapy of Empagliflozin and Linagliptin Versus Metformin and Insulin Glargine on Blood Pressure and Vascular Function in Patients with Type 2 Diabetes
by: Christian Ott, et al.
Published: (2020-02-01)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
by: von Websky K, et al.
Published: (2013-11-01)

Clinical efficacy and safety of linagliptin in patients with diabetes type 2
by: E. V. Biryukova, et al.
Published: (2016-12-01)

Linagliptin use in older individuals with type 2 diabetes
by: Pratley RE
Published: (2014-07-01)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
by: Hoimark L, et al.
Published: (2012-08-01)

Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design
by: Sushant B. Jadhav, et al.
Published: (2016-10-01)

Linagliptin in the frail elderly diabetic patient
by: Eva Palmieri
Published: (2018-09-01)

Safety and efficacy of initial combination of linagliptin and metformin in patients with type 2 diabetes: A subgroup analysis of Indian patients from a randomized, double-blind, placebo-controlled study
by: Vaishali Deshmukh, et al.
Published: (2015-01-01)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
by: Gallwitz B
Published: (2013-01-01)

Clinical utility and tolerability of linagliptin in diabetic patients
by: Maxwell LG, et al.
Published: (2013-03-01)

A Localized Painful Rash Induced by Linagliptin in a Patient with type 2 Diabetes
by: İsmail Yıldız, et al.
Published: (2019-05-01)

Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
by: Gallwitz B
Published: (2015-05-01)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
by: Scott D
Published: (2013-10-01)

Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials
by: Janet B. McGill
Published: (2012-08-01)

Linagliptin—A Novel Dipeptidyl Peptidase Inhibitor for Type 2 Diabetes Therapy
by: Baptist Gallwitz
Published: (2012-01-01)

Linagliptin–-A Novel Dipeptidyl Peptidase Inhibitor for Type 2 Diabetes Therapy
by: Baptist Gallwitz
Published: (2012-01-01)

Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice
by: Nikita Nirwan, et al.
Published: (2022-07-01)

Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors
by: Baptist Gallwitz
Published: (2013-06-01)

Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012-06-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
by: Jonathan K Reynolds
Published: (2009-07-01)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014-07-01)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
by: Molly G. Minze, et al.
Published: (2013-07-01)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
by: Molly G. Minze, et al.
Published: (2013-01-01)

Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin
by: Ömercan Topaloğlu, et al.
Published: (2019-03-01)

Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan
by: Soulmaz Fazeli Farsani, et al.
Published: (2019-09-01)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
by: Hiroshi Takahashi, et al.
Published: (2019-05-01)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
by: Henrik H. Hansen, et al.
Published: (2021-04-01)

Simultaneous quantification of empagliflozin, linagliptin and metformin hydrochloride in bulk and synthetic mixture by RP–LC method
by: Ishita M. Patel, et al.
Published: (2021-08-01)

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
by: Singh AK, et al.
Published: (2021-07-01)

Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle
by: Mildred Fátima de la Luz Alvarez-Canales, et al.
Published: (2021-04-01)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
by: Marc K Israel, et al.
Published: (2008-12-01)

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
by: Bo Ahrén
Published: (2008-04-01)

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination
by: Panagoulias GS, et al.
Published: (2014-02-01)

Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin
by: Farr AM, et al.
Published: (2016-08-01)

Population Pharmacokinetic/Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus
by: Yusuke Tadayasu, et al.
Published: (2013-12-01)

Effect of empagliflozin versus linagliptin on body composition in Asian patients with type 2 diabetes treated with premixed insulin
by: Yi-Hong Zeng, et al.
Published: (2022-10-01)

The efficacy of metformin in the treatment of type 2 diabetes
by: А. S. Ametov, et al.
Published: (2016-12-01)